Regeneron (REGN) Q3 Earnings Beat, REGEN-COV Boosts Growth

Published on November 4, 2021

Regeneron (REGN) beats on Q3 earnings while sales record strong year-over-year growth on the solid performance of Dupixent and Eylea, and incremental contribution from REGEN-COV.

Continue reading on website
Other news

Propelo raises $12M for its AI-driven engineering excellence platform

November 4, 2021
The number of DevOps tools has increased exponentially over the last few years and, with that, the amount of data these tools can produce to help businesses improve their software development processes. But most of the time, this data simply ends up in a dashboard for some scattershot analysis. Propelo (previously known as LevelOps) wants to bring order to this chaos and aims to build an “AI-drive

Is A.P. MollerMaersk (AMKBY) a Great Value Stock Right Now?

November 4, 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to...